📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
0 analysed today
FollowTelegram
0
Today
152,139
All-time analysed
43,645
Positive
6,747
Negative
92,898
Neutral
8,781
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
73 announcements match the current filters (relevance ≥ 5).
UGRO Capital Approves Fundraise of up to ₹700 Crores via NCD Issuance
UGRO Capital's Investment and Borrowing Committee has approved the issuance of Non-Convertible Debentures (NCDs) on a private placement basis. The issue features a base size of ₹200 Crores with a green shoe option to retain oversubscription of up to ₹500 Crores, totaling a potential ₹700 Crores. The NCDs are divided into four series with tenures ranging from 13 to 24 months. This capital infusion is intended to support the company's lending operations and liquidity management.
Key Highlights
Base issue size of ₹200 Crores with a Green Shoe option of ₹500 Crores.
Issuance consists of four series, with Series 1-3 being secured and Series 4 being unsecured.
Tenures range from 13 months (Series 3) to 24 months (Series 1, 2, and 4).
Series 2 carries a tentative coupon rate of 9.75% per annum with quarterly interest payments.
Security cover for secured series is set at 1.1x or through specific asset/investment pledges.
👀 What to Watch
Investors should monitor the successful completion of this fundraise as it provides necessary capital for UGRO's MSME lending growth. The 9.75% tentative coupon for Series 2 indicates the current cost of borrowing for the firm, which is a key metric for NBFC profitability.
UGRO Capital Allots Secured NCDs Worth INR 150 Crore at 9.99% Interest
UGRO Capital has successfully allotted 1,50,000 secured, non-convertible debentures (NCDs) through a private placement, raising a total of INR 150 crore. These instruments carry a coupon rate of 9.99% per annum, with interest payable on a monthly basis. The NCDs have a tenure of 42 months and are backed by a security cover of 1.10x over the company's loan receivables. This capital infusion is expected to support the company's ongoing lending operations and growth strategy.
Key Highlights
Allotment of 1,50,000 NCDs with a face value of INR 10,000 each, totaling INR 150 crore
Fixed coupon rate of 9.99% per annum with a monthly payment schedule
Instrument tenure is 42 months with a maturity date set for June 16, 2029
Secured by a minimum 1.10x cover on present and future loan receivables
The NCDs will be listed on the BSE Limited for secondary market trading
👀 What to Watch
Investors should monitor the company's deployment of these funds into high-yield SME lending to ensure net interest margins remain stable. The successful fundraise at a sub-10% rate indicates healthy credit confidence in the NBFC.
UGRO Capital Raises ₹150 Crore via Allotment of Secured NCDs at 9.99% Coupon
UGRO Capital has successfully allotted 1,50,000 secured, non-convertible debentures (NCDs) on a private placement basis to raise ₹150 crore. These instruments carry a coupon rate of 9.99% per annum with interest payable on a monthly basis. The NCDs have a tenure of 42 months and are scheduled to mature on June 16, 2029. This capital infusion is intended to support the company's lending operations and growth in the MSME financing sector.
Key Highlights
Allotment of 1,50,000 NCDs with a face value of ₹10,000 each, totaling ₹150 crore.
Fixed coupon rate of 9.99% per annum with a monthly interest payment schedule.
Tenure of 42 months with a final maturity date set for June 16, 2029.
Maintains a minimum security cover of 1.10x over loan receivables at all times.
👀 What to Watch
Investors should monitor how efficiently this capital is deployed to maintain margins against the 9.99% borrowing cost. The successful fundraise indicates healthy credit appetite for the company's debt paper.
Ugro Capital Board to Meet on December 17 to Approve Fundraise via NCDs
Ugro Capital has announced a meeting of its Investment and Borrowing Committee scheduled for December 17, 2025. The committee will consider and approve the raising of funds through the issuance of Non-Convertible Debentures (NCDs) on a private placement basis. This move is a standard capital-raising activity for the NBFC to support its lending operations and growth in the MSME sector. While the specific amount has not been disclosed yet, the outcome of the meeting will determine the scale of the capital infusion.
Key Highlights
Investment and Borrowing Committee meeting scheduled for December 17, 2025.
Proposal to raise funds via issuance of Non-Convertible Debentures (NCDs).
Fundraising to be conducted through a private placement basis.
Complies with SEBI Listing Obligations and Disclosure Requirements (LODR) Regulations.
👀 What to Watch
Investors should monitor the post-meeting announcement on December 17 for the specific quantum of funds and the interest rates offered. Successful capital raising at competitive rates is essential for the company's credit growth and margin stability.
UGROCAP Allots 15,89,170 Equity Shares on CCD Conversion
Ugro Capital Limited has allotted 15,89,170 equity shares following the conversion of Compulsorily Convertible Debentures (CCDs). The conversion price was ₹185 per share, including a premium of ₹175. This allotment increases the company's issued, subscribed, and paid-up equity share capital from ₹1,52,58,34,950 to ₹1,54,17,26,650. The new shares rank equally with existing shares.
Key Highlights
Allotted 15,89,170 Equity Shares
Conversion price of ₹185 per share
Premium of ₹175 per equity share
Equity share capital increased to ₹1,54,17,26,650 from ₹1,52,58,34,950
CCDs converted into equity shares
👀 What to Watch
Investors should note the increase in equity share capital. Monitor the company's performance and financial statements for any impact from this conversion.
Ugro Capital Allots Unlisted Commercial Papers of ₹50 Crores
Ugro Capital Limited has announced the allotment of unlisted Commercial Papers (CPs) worth ₹50 Crores. The allotment was approved by the Investment and Borrowing Committee of the Board of Directors on December 10, 2025. These CPs have a face value of ₹5,00,000 per security and were issued at a price of ₹4,95,964.50 per security. The redemption date is set for January 12, 2026, with a redemption value of ₹50,00,00,000.
Key Highlights
Allotted unlisted Commercial Papers worth ₹50 Crores.
Face value per security is ₹5,00,000.
Issue price per security is ₹4,95,964.50.
Redemption value is ₹50,00,00,000.
Tenure of the security is 33 Days.
👀 What to Watch
Investors should note the company's short-term funding strategy and monitor its impact on the company's financials. Review the company's future announcements regarding debt and financial performance.
UGRO Capital Completes 100% Acquisition of Profectus Capital; AUM Reaches ₹15,471 Cr
UGRO Capital has finalized the 100% acquisition of Profectus Capital, expanding its consolidated AUM by 29% to ₹15,471 crore. The deal is highly accretive, providing an immediate ₹150 crore in annualized profit and an additional ₹115 crore in expected operating synergies. The acquisition shifts the company's asset mix to 75% secured, which is projected to improve Return on Assets (ROA) by 60-70 bps. Furthermore, the transaction opens a new ₹2,000 crore medium-term market opportunity in school financing.
Key Highlights
Consolidated AUM grew by 29% to ₹15,471 crore with the addition of Profectus's ₹3,468 crore book
Immediate annualized profit accretion of ₹150 crore delivered on Day 1 with zero origination cost
Expected operating synergies of ₹115 crore to drive a 60-70 bps improvement in ROA
Asset mix significantly strengthened to 75% secured, enhancing earnings stability and credit-cost profiles
Entry into school financing creates a new ₹2,000 crore medium-term growth vertical
👀 What to Watch
Investors should view this acquisition as a significant positive catalyst for earnings growth and ROE improvement. Monitor the upcoming formal merger process and the realization of the projected ₹115 crore in operating synergies.
UGROCAP acquires Profectus Capital as wholly owned subsidiary
UGRO Capital Limited has completed the acquisition of 100% shareholding in Profectus Capital Private Limited, making it a wholly owned subsidiary effective December 8, 2025. This acquisition was initially announced on June 17, 2025, and received RBI approval as disclosed on September 18, 2025. The acquisition was executed under the Share Purchase Agreement (SPA) dated June 17, 2025. This move is expected to strengthen UGRO Capital's position in the market.
Key Highlights
Acquired 100% shareholding in Profectus Capital Private Limited
Profectus is now a wholly owned subsidiary of UGRO Capital effective December 8, 2025
Acquisition follows Share Purchase Agreement (SPA) dated June 17, 2025
RBI approval received as per disclosure on September 18, 2025
👀 What to Watch
Investors should monitor UGRO Capital's performance and integration of Profectus Capital to assess the long-term benefits of this acquisition. Keep an eye on future announcements regarding synergies and financial impact.
UGROCAP: Allotment of 7,342,732 Equity Shares on CCD Conversion
UGRO Capital has allotted 7,342,732 equity shares due to the conversion of Compulsorily Convertible Debentures (CCDs). The conversion was triggered as the 18-month tenure of CCDs allotted on June 6, 2024, expired. The face value of each equity share is ₹10, and the conversion price was ₹264 (including a premium of ₹254). Consequently, the issued, subscribed, and paid-up equity share capital increased from 14,52,40,763 shares (₹1,45,24,07,630) to 15,25,83,495 shares (₹1,52,58,34,950). Additionally, 1,76,34,374 warrants that were not converted have lapsed.
Key Highlights
Allotted 7,342,732 Equity Shares on CCD conversion
Equity share face value is ₹10 each
Conversion price of ₹264 per share (including ₹254 premium)
Issued capital increased to 15,25,83,495 equity shares, amounting to ₹1,52,58,34,950
1,76,34,374 warrants lapsed due to non-conversion
👀 What to Watch
Investors should note the increase in equity share capital and potential dilution. Monitor the company's performance and future announcements regarding warrant conversions.
UGROCAP Allots Commercial Papers worth ₹30,00,00,000
UGRO Capital Limited has announced the allotment of Commercial Papers (CPs) worth ₹30,00,00,000. The allotment date is December 5th, 2025, and the redemption date is June 3rd, 2026, giving the security a tenure of 180 days. The face value per security is ₹5,00,000, while the issue price is ₹4,78,525.50 per security. The ISIN for these CPs is INE583D14766.
Key Highlights
Allotment of Commercial Papers worth ₹30,00,00,000
Face Value per Security: ₹5,00,000
Issue Price per Security: ₹4,78,525.50
Tenure of the security: 180 days
Redemption Date: June 3rd, 2026
👀 What to Watch
Investors should monitor UGRO Capital's financial performance and its ability to meet its obligations related to these commercial papers. Review the company's credit ratings for further insights.
UGROCAP Allots Commercial Papers worth ₹30 Crore
UGRO Capital Limited has announced the allotment of Commercial Papers (CPs) worth ₹30,00,00,000. The allotment date is December 05, 2025, and the redemption date is June 03, 2026, giving the security a tenure of 180 days. The face value per security is ₹5,00,000, with an issue price of ₹4,78,525.50 per security and an issue value of ₹28,71,15,300. The ISIN for these CPs is INE583D14766, and Yes Bank Limited, Mumbai, is the IPA.
Key Highlights
Allotted Commercial Papers worth ₹30,00,00,000
Tenure of the security is 180 days
Issue price per security is ₹4,78,525.50
Redemption date is June 03, 2026
Face Value per Security (Rs.) 5,00,000
👀 What to Watch
Investors should monitor UGRO Capital's financial performance and its ability to meet its debt obligations. Keep an eye on the company's announcements regarding future fundraising activities.
UGROCAP: Credit Ratings Affirmed & Assigned; Commercial Paper at IND A1+
India Ratings & Research Pvt. Ltd. has affirmed the IND A1+ rating for Ugro Capital's commercial paper and maintained a 'Rating Watch with Positive Implications' on its bank loan and non-convertible debentures. The rating agency assigned IND A1+ rating to commercial paper of ₹3,000 million. The current amount for bank loan is ₹68,000 million and for Non-Convertible Debentures is ₹30014.2 million. Investors should note the increased amount of commercial paper from ₹3,000 million to ₹5,000 million.
Key Highlights
Commercial paper rating affirmed at IND A1+ for ₹5,000 million.
Bank Loan rating maintained at IND A+/Rating Watch with Positive Implications for ₹68,000 million.
Non-Convertible Debentures rating maintained at IND A+/Rating Watch with Positive Implications for ₹30014.2 million.
Commercial paper rating assigned at IND A1+ for ₹3,000 million.
Subordinated Debt rating maintained at IND A+/Rating Watch with Positive Implications for ₹6,500 million.
👀 What to Watch
Monitor Ugro Capital's progress regarding the 'Rating Watch with Positive Implications' and assess any potential upgrades. Review the company's financial performance in light of these credit ratings.
UGROCAP to issue NCDs of up to ₹75 Crore + Green Shoe Option of ₹75 Crore
UGRO Capital plans to issue listed, rated, senior, secured, transferable, redeemable, Non-Convertible Debentures (NCDs) on a private placement basis. The base issue size is up to ₹75,00,00,000 with an option to retain oversubscription up to ₹75,00,00,000 (Green Shoe Option). The NCDs have a tenure of 42 months and offer a coupon rate of 9.99% per annum payable monthly. The tentative date of allotment is December 10, 2025, and the maturity date is June 10, 2029.
Key Highlights
Issuance of NCDs up to ₹75,00,00,000 (Base Issue Size)
Green Shoe Option to retain oversubscription up to ₹75,00,00,000
Coupon/interest offered at 9.99% per annum payable monthly
Tenure of the instrument is 42 months
Security cover of at least 1.10 times or 110% against outstanding NCDs
👀 What to Watch
Investors should note the terms of the NCDs, including the interest rate and security, and consider how this fundraising might impact the company's future growth and profitability. Monitor the company's performance and debt levels following the issuance.
